BCYC
Bicycle Therapeutics Ltd
NASDAQ: BCYC · HEALTHCARE · BIOTECHNOLOGY
$4.72
-0.21% today
Updated 2026-04-30
Market cap
$337.89M
P/E ratio
—
P/S ratio
4.66x
EPS (TTM)
$-3.16
Dividend yield
—
52W range
$4 – $10
Volume
0.5M
Bicycle Therapeutics Ltd (BCYC) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+40.1%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+2.4%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+6.6%
2025-10-29
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-03 | $-0.29 | +69.1% | $5.73 | $5.63 | -1.7% |
| 2025-10-29 | $-0.85 | +12.4% | $8.22 | $8.76 | +6.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.90 | $0.00 | +100.0% | — | — |
| 2025-12-31 | $-0.94 | $-0.29 | +69.1% | $47.95M | +1193.3% |
| 2025-09-30 | $-0.97 | $-0.85 | +12.4% | $11.73M | +338.5% |
| 2025-06-30 | $-0.94 | $-1.14 | -21.3% | $2.92M | -68.8% |
| 2025-03-31 | $-0.81 | $-0.88 | -8.8% | $9.98M | -48.9% |
| 2024-12-31 | $-0.85 | $-0.81 | +4.6% | $3.71M | -30.4% |
| 2024-09-30 | $-0.78 | $-0.74 | +5.1% | $2.68M | -50.0% |
| 2024-06-30 | $-1.10 | $-0.77 | +30.0% | $9.36M | -17.9% |
| 2024-03-31 | $-1.24 | $-0.62 | +50.0% | $19.53M | — |
| 2023-12-31 | $-1.23 | $-1.16 | +5.7% | $5.33M | — |
| 2023-09-30 | $-1.17 | $-1.26 | -7.7% | $5.35M | — |
| 2023-06-30 | $-1.29 | $-1.41 | -9.3% | $11.40M | — |
Frequently asked questions
Has Bicycle Therapeutics Ltd beaten earnings estimates?
Bicycle Therapeutics Ltd has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +40.1% over the last 4 quarters.
How does BCYC stock react to earnings?
BCYC stock has moved an average of +2.4% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.